a shift in patient consultation and the rising role of facial volume restoration IRVINE, Calif., March 4, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, shares new data illustrating how the rapid adoption of Medical Weight Loss (MWL) treatments is changing patient behavior, aesthetic priorities, and treatment demand, particularly as facial volume loss emerges as a leading concern
HSA and FSA accounts are accepted at PlexusDx, making personalized semaglutide therapy even more accessible for eligible patients
The Wolverine stack enters first, with body composition peptides added later if needed
Early data suggest that petrelintide might offer improved tolerability and effective weight loss compared to existing treatments
For each subgroup analysis, propensity-score matching with machine learning methods was repeated specifically within the subgroups of interest to construct treatment and control cohorts
Ritual used to be just one way we marked the stages of our lives